BioLineRx (BLRX) Short-term Investments (2010 - 2026)
BioLineRx (BLRX) reported Short-term Investments of $8.45 million for the quarter ended Jun 30, 2026, compared with -$24.82 million a year earlier and down 43.1% from the prior quarter.
Powered by 
Analysis
BioLineRx (BLRX) Short-term Investments (2010 - 2026) Analysis & Trends
As of Dec 31, 2025, BioLineRx posted Short-term Investments of $17.63 million, up 93.1% from the prior year.
- By year, Short-term Investments came in at $9.13 million in the year ended Dec 31, 2024, -$47.59 million in the year ended Dec 31, 2023, -$44 million in the year ended Dec 31, 2022 and -$78 million in the year ended Dec 31, 2021.
- Five-year quarterly Short-term Investments spans a low of -$78 million in the quarter ended Dec 31, 2021 and a high of $44.16 million in the quarter ended Sep 30, 2022.
- The high point for year-over-year Short-term Investments in five years was the quarter ended Dec 31, 2025 (growth of 93.1%); the low point was the quarter ended Sep 30, 2023 (a decline of 58.7%).
- Per Business Quant data, the three quarters before the quarter ended Jun 30, 2026 came in at $14.85 million (quarter ended Mar 31, 2026), $17.63 million (quarter ended Dec 31, 2025) and $17.3 million (quarter ended Sep 30, 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn |
| 10 | BioLineRx | 8.48 Mn | -68.04 Mn | 235,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 8.45 Mn |
| Mar 31, 2026 | 14.85 Mn |
| Dec 31, 2025 | 17.63 Mn |
| Sep 30, 2025 | 17.30 Mn |
| Jun 30, 2025 | 20.97 Mn |
| Mar 31, 2025 | 17.33 Mn |
| Dec 31, 2024 | 9.13 Mn |
| Sep 30, 2024 | 20.34 Mn |
| Jun 30, 2024 | 30.44 Mn |
| Mar 31, 2024 | 22.18 Mn |
| Dec 31, 2023 | 38.74 Mn |
| Sep 30, 2023 | 18.24 Mn |
| Jun 30, 2023 | 22.71 Mn |
| Mar 31, 2023 | 34.22 Mn |
| Dec 31, 2022 | 40.50 Mn |
| Sep 30, 2022 | 44.16 Mn |
| Jun 30, 2022 | 29.15 Mn |
| Mar 31, 2022 | 39.14 Mn |
| Dec 31, 2021 | 44.15 Mn |
| Sep 30, 2021 | 48.13 Mn |
API Access
BioLineRx Short-term Investments API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=short-term-investments&ticker=BLRX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "short-term-investments", "ticker": "BLRX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=short-term-investments&ticker=BLRX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();